161 related articles for article (PubMed ID: 35331976)
1. Denosumab for central giant cell granuloma in an Australian tertiary paediatric centre.
Vanderniet JA; Wall CL; Mullins A; London K; Lim L; Hibbert S; Briody J; Padhye B; Poon M; Biggin A; Dalla-Pozza L; Munns CF
Bone; 2022 Jun; 159():116395. PubMed ID: 35331976
[TBL] [Abstract][Full Text] [Related]
2. Surgical Management and Denosumab for Aneurysmal Bone Cysts of the Spine in an Australian Tertiary Paediatric Centre.
Vanderniet JA; Tsinas D; Wall CL; Girgis CM; London K; Keane C; Briody J; Hibbert S; Poon M; Padhye B; Biggin A; Dalla-Pozza L; Gray RJ; Munns CF
Calcif Tissue Int; 2023 May; 112(5):592-602. PubMed ID: 36810677
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Radiologic Response of Central Giant Cell Granuloma to Denosumab: A 6-Year Prospective Observational Study.
Rhou YJJ; Wang CJ; Nguyen M; Vanderniet JA; Munns CF; Coleman H; Kim J; Holmes-Walker DJ; Lim L; Girgis CM
Calcif Tissue Int; 2022 Apr; 110(4):464-474. PubMed ID: 35088118
[TBL] [Abstract][Full Text] [Related]
4. Treatment of central giant cell granuloma in children with denosumab.
Choe M; Smith V; Okcu MF; Wulff J; Gruner S; Huisman TAGM; Venkatramani R
Pediatr Blood Cancer; 2021 Mar; 68(3):e28778. PubMed ID: 33089644
[TBL] [Abstract][Full Text] [Related]
5. Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review.
Tsukamoto S; Tanaka Y; Mavrogenis AF; Kido A; Kawaguchi M; Errani C
Clin Orthop Relat Res; 2020 May; 478(5):1076-1085. PubMed ID: 31794487
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Post-denosumab Rebound Hypercalcaemia in Bony-Metastatic Breast Cancer.
Wang R; Rajanayagam S; Ngan J; Renouf DA
Calcif Tissue Int; 2022 Oct; 111(4):391-395. PubMed ID: 35809111
[TBL] [Abstract][Full Text] [Related]
7. Osteonecrosis of the Jaw and Rebound Hypercalcemia in Young People Treated With Denosumab for Giant Cell Tumor of Bone.
Uday S; Gaston CL; Rogers L; Parry M; Joffe J; Pearson J; Sutton D; Grimer R; Högler W
J Clin Endocrinol Metab; 2018 Feb; 103(2):596-603. PubMed ID: 29211870
[TBL] [Abstract][Full Text] [Related]
8. Successful denosumab treatment for central giant cell granuloma in a 9-year-old child.
Mariz BALA; Migliorati CA; Alves FA; Penteado FM; Carvalho NP; Santos-Silva AR; Rocha AC
Spec Care Dentist; 2021 Jul; 41(4):519-525. PubMed ID: 33760257
[TBL] [Abstract][Full Text] [Related]
9. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
Müller DA; Beltrami G; Scoccianti G; Campanacci DA; Franchi A; Capanna R
World J Surg Oncol; 2016 Nov; 14(1):281. PubMed ID: 27809843
[TBL] [Abstract][Full Text] [Related]
10. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.
Chawla S; Blay JY; Rutkowski P; Le Cesne A; Reichardt P; Gelderblom H; Grimer RJ; Choy E; Skubitz K; Seeger L; Schuetze SM; Henshaw R; Dai T; Jandial D; Palmerini E
Lancet Oncol; 2019 Dec; 20(12):1719-1729. PubMed ID: 31704134
[TBL] [Abstract][Full Text] [Related]
11. Effect of denosumab on recurrent giant cell reparative granuloma of the lumbar spine.
Akeda K; Kasai Y; Sakakibara T; Matsumine A; Takegami N; Yamada J; Sudo A
Spine (Phila Pa 1976); 2015 May; 40(10):E601-8. PubMed ID: 25955096
[TBL] [Abstract][Full Text] [Related]
12. A case of pelvic giant cell tumor of bone, complete remission with denosumab: long duration of response.
Bilgetekin I; Mammadkhanli O; Basal FB; Kandemir O; Canbay S; Oksuzoglu B
Anticancer Drugs; 2020 Jun; 31(5):533-535. PubMed ID: 31743134
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
Traub F; Singh J; Dickson BC; Leung S; Mohankumar R; Blackstein ME; Razak AR; Griffin AM; Ferguson PC; Wunder JS
Eur J Cancer; 2016 May; 59():1-12. PubMed ID: 26990281
[TBL] [Abstract][Full Text] [Related]
14. Radiological findings of denosumab treatment for giant cell tumours of bone.
van Langevelde K; McCarthy CL
Skeletal Radiol; 2020 Sep; 49(9):1345-1358. PubMed ID: 32335707
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases.
Deveci MA; Paydaş S; Gönlüşen G; Özkan C; Biçer ÖS; Tekin M
Acta Orthop Traumatol Turc; 2017 Jan; 51(1):1-6. PubMed ID: 27784623
[TBL] [Abstract][Full Text] [Related]
16. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
Agarwal MG; Gundavda MK; Gupta R; Reddy R
Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215
[TBL] [Abstract][Full Text] [Related]
17. Denosumab as treatment of central giant cell granuloma of the jaws. a scoping review.
Latorre CG; Atalah CN; Marshall Baburizza M
Oral Maxillofac Surg; 2024 Mar; ():. PubMed ID: 38539018
[TBL] [Abstract][Full Text] [Related]
18. Denosumab: an Emerging Therapy in Pediatric Bone Disorders.
Boyce AM
Curr Osteoporos Rep; 2017 Aug; 15(4):283-292. PubMed ID: 28643220
[TBL] [Abstract][Full Text] [Related]
19. A new computerized tomography classification to evaluate response to Denosumab in giant cell tumors in the extremities.
Campanacci L; Sambri A; Medellin MR; Cimatti P; Errani C; Donati DM
Acta Orthop Traumatol Turc; 2019 Sep; 53(5):376-380. PubMed ID: 31253385
[TBL] [Abstract][Full Text] [Related]
20. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.
Zhang RZ; Ma TX; Qi DW; Zhao M; Hu T; Zhang GC
Orthop Surg; 2019 Dec; 11(6):1101-1108. PubMed ID: 31762217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
